Home > Boards > US Listed > Biotechs > Lifeline Biotech ( LLBT LLBO)

It still SUX!

Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
headcounselor Member Profile
 
Followed By 7
Posts 844
Boards Moderated 0
Alias Born 03/15/07
160x600 placeholder
Canada, Pfizer Strike Deal on Pediatric Vaccine Doses
By Paul Vieira
FTSE 100 Closes Down as Evergrande Concerns Linger
STOXX Europe 50 Index Ends 0.21% Lower at 3616.29 -- Data Talk
CAC 40 Index Ends 0.29% Lower at 6686.17 -- Data Talk
FTSE 100 Index Ends 0.45% Lower at 7190.30 -- Data Talk
DAX Ends 0.32% Lower at 15472.56 -- Data Talk
EURO STOXX 50 Index Ends 0.39% Lower at 4155.73 -- Data Talk
L'Oreal Posts Higher 3Q Sales on Growth in All Regions, Divisions
STOXX Europe 600 Index Ends 0.08% Lower at 469.71 -- Data Talk
Vivendi Third-Quarter Revenue Rose Amid Canal+ Growth
Home Depot On Pace for Sixth Consecutive Record High Close -- Data Talk
Top Company News of the Day
Tesla on Pace for Record High Close -- Data Talk
IBM Down Nearly 7%, On Pace for Largest Percent Decrease Since January -- Data Talk
U.S. Leading Economic Index Rose in September, But Signals Slowdown -- The Conference Board
UK Sells GBP6Bln in July 2053 Green Gilt via Syndication
Markit Flash Manufacturing PMI on the Docket -- Data Week Ahead
Mortgage Rates Exceed 3% in Latest Week
Klarna to Offer Buy-Now-Pay-Later Option on Wix Websites
VC Daily: ShouTi Lands $100 Million to Develop Pills for Chronic Diseases
Exxon Plans $400 Million Expansion of Carbon Capture Facility in Wyoming
Soybean Sales Perk Up
Philly's Fed District Manufacturing Activity Eased in October
Fed's Quarles Warns of Extended High Inflation; Paycheck Protection Program May Have Made Inequality Worse, Minneapolis Fed Chief Says
U.S. Jobless Claims Fell 6K to 290K in Oct. 16 Week
Sio Gene Therapies Gets FDA Fast-Track Designation for AXO-AAV-GM1 in GM1 Gangliosidosis
Union Pacific Earnings Grow, With Revenue Carloads Flat
Essential Utilities to Buy City of Beaver Falls Municipal Wastewater Assets
Intellia Gets FDA Orphan Designation for NTLA-2001 in ATTR Amyloidosis
Pfizer, BioNTech: Phase 3 Study Shows High Efficacy of Covid-19 Vaccine Booster
headcounselor   Monday, 08/10/09 09:48:35 PM
Re: None
Post # of 6377 
It still SUX!

Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences